Search Results

Christoph Boesecke MD completed his medical studies at Charité University in Berlin, Germany. He received his Doctorate in Medicine from the University of Hamburg, Germany for his research in acute HIV infection. He held a 2-year postgraduate position studying integrase inhibitors in acute and chronic HIV infection at the National Centre in HIV Epidemiology and […]

The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1 Currently, there are an estimated 30 million people on antiretroviral treatment for HIV globally, of whom approximately 70% reside in Africa.2 Despite advancements in the provision of antiretroviral therapy […]

Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1 Worldwide, RSV is the second leading cause of death (second to malaria) in children during their first year of life.2 Elderly people (>60 years of age) are also at an increased risk […]

HIV vaccine development harnesses breakthroughs in structure-based antigen design, sequencing, and single-cell analysis to create potent vaccines. Prof. Barney Graham, Professor of Medicine, Microbiology, Chemistry and Immunology, Morehouse School of Medicine in Atlanta, Georgia, USA explores advances reported at CROI 2024, emphasizing advances in targeting antibody lineages and augmenting CD8+ T cell responses, and highlighting sustaining funding models for HIV research and it's imperativeness for addressing broader public health issues.

HIV vaccine development, emphasizing HIV, RSV, and coronavirus COVID-19 research is discussed by Prof. Barney Graham. This information is crucial for immunologists, virologists, and those in vaccine research. Learn from cross-disciplinary strategies. You, as healthcare professionals in these fields, need to grasp these insights for innovation. HIV, RSV, and coronavirus studies offer valuable lessons. Keep up with the latest in vaccine technology.

HIV diagnostic technologies are rapidly advancing, as Dr. Nitika Pai discussed, with self-tests and multiplex testing leading the way in accuracy and accessibility. The challenge remains in cost and strategic deployment. This field interests infectious disease specialists, clinical epidemiologists, and public health professionals. Stay informed on innovations like CRISPR and machine learning to enhance patient care. NAT (Nucleic Acid Test) costs and algorithmic bias in machine learning need attention for equitable access.

HIV diagnostics have transformed post-COVID, enhancing the acceptance and implementation of self-tests globally. Dr Nitika Pai, Division of Clinical Epidemiology, Experimental Medicine, Infectious Disease, McGill University, Montreal, Canada, discusses advancements in HIV diagnostics, especially self-testing, which has increased the acceptance and implementation of HIV self-tests globally.